SCHEDULE: Aevum Pension Fund Discloses 4.86% Stake in Accuray Inc.
Beneficial Ownership Report
Aevum Pension Fund reported a 4.86% beneficial ownership stake in Accuray Inc. common stock, holding 5,473,256 shares as of September 30, 2024.
Summary
- Aevum Pension Fund, a Swiss-based entity, has filed an Amendment No. 3 to Schedule 13G, disclosing its beneficial ownership in Accuray Inc.
- As of September 30, 2024, Aevum Pension Fund beneficially owns 5,473,256 shares of Accuray Inc. Common Stock.
- This ownership represents 4.86% of the total class of Accuray Inc. Common Stock.
- Aevum Pension Fund holds sole voting power and sole dispositive power over all 5,473,256 shares.
- The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Accuray Inc.
Sentiment
Score: 5
Explanation: The filing is a routine beneficial ownership disclosure, indicating a passive investment without expressing a specific sentiment towards the issuer's performance or future prospects.
Positives
- Aevum Pension Fund, a Swiss pension fund, holds a significant stake, indicating institutional confidence in Accuray Inc. as a long-term investment.
- The filing certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- NA
Industry Context
NA
Comparison to Industry Standards
- NA
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor's stake provides transparency regarding the ownership structure of Accuray Inc.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of event which requires the filing of this statement (beneficial ownership calculation date). |
| 10/02/2025 | Signature date of the filing by Blaise Hatt-Arnold, Director of Aevum Pension Fund. |
Keywords
Accuray Inc., Aevum Pension Fund, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor, Medical Devices, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.